Corticotropin-releasing factor enhances noradrenaline release in the rat hypothalamus assessed by intracerebral microdialysis.
Corticotropin-releasing factor (CRF) at a dose of 3 micrograms administered intracerebroventricularly (i.c.v.) elicited increases in noradrenaline (NA) release, which was assessed by intracerebral microdialysis in the anterior hypothalamus of conscious rats. These increases persisted until 140 min after infusion of CRF. These results indicate that CRF enhances NA release in the hypothalamus, an effect which may underlie the 'stress-like' properties of CRF.
Emoto
H
H
Department of Pharmacology, Kurume University School of Medicine, Japan.
Yokoo
H
H
Yoshida
M
M
Tanaka
M
M
D000818:Animals; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology*; D003956:Dialysis; D007032:Hypothalamus, Anterior / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*; D007276:Injections, Intraventricular; D008297:Male; D009638:Norepinephrine / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar
D003346:Corticotropin-Releasing Hormone; D009638:Norepinephrine